Search
01/05/2025
Circulating tumor DNA in muscle-invasive bladder cancer: A systematic review
Grosso, AA, Cadenar, A, Pillozzi, S, Carli, G, Lipparini, F, Di Maida, F, Pichler, R, Krajewski, W, Albisinni, S, Laukhtina, E, Mancon, S, del Giudice, F, Mir, MC, Soria, F, Moschini, M, Shariat, SF, Roupret, M, Teoh, JYC, Antonuzzo, L, Breda, A, Minervini, A, Gallioli, A, Mari, A. Circulating tumor DNA in muscle-invasive bladder cancer: A systematic review. Actas Urologicas Espanolas. 2025; 49(4)DOI:10.1016/j.acuro.2025.501717. PMID:39952561. IF:1.200(Q3/7D).
01/05/2025
Novel risk factors for venous thromboembolism following outpatient or inpatient transurethral resection of bladder tumors: Multivariable stepwise and LASSO regression modeling from us insurance claim database
Laszkiewicz, J, del Giudice, F, Li, S, Krajewski, W, Nowak, L, Szydelko, T, Basran, S, De Berardinis, E, Carino, D, Corvino, R, Santerelli, V, Ferro, M, Rocco, B, Sighinolfi, MC, Crocetto, F, Barone, B, Dinacci, F, Pichler, R, Subiela, JD, Pradere, B, Moschini, M, Mari, A, Gallioli, A, Mori, K, Soria, F, Mertens, L, Abu-Ghanem, Y, Nair, R, Khan, MS, Chung, BI. Novel risk factors for venous thromboembolism following outpatient or inpatient transurethral resection of bladder tumors: Multivariable stepwise and LASSO regression modeling from us insurance claim database. Actas Urologicas Espanolas. 2025; 49(4)DOI:10.1016/j.acuro.2025.501738. PMID:40107612. IF:1.200(Q3/7D).
01/05/2025
Use of Postoperative Radiotherapy and Multiple Adjuvant Treatments After Surgical Removal of a Giant Retroauricular Keloid in a Pediatric Patient
Sicre, JE, Ivars, M, Heinz, OH, Ludwig, PW, Verdun, JI, Torres, EB. Use of Postoperative Radiotherapy and Multiple Adjuvant Treatments After Surgical Removal of a Giant Retroauricular Keloid in a Pediatric Patient. PEDIATRIC DERMATOLOGY. 2025; 42(3)DOI:10.1111/pde.15787. PMID:39491479. IF:1.200(Q3/7D).
01/05/2025
influence the interval time between surgery and start of adjuvant radiotherapy for head and neck cancer prognosis
Crespo, SM, Montezuma, LC, Leon, X, Majercakova, K, Rojas, J, Calvet, G, Rabi, S, Piedra, MM, Juliá, JC, Sancho, G. influence the interval time between surgery and start of adjuvant radiotherapy for head and neck cancer prognosis. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).
01/05/2025
Prognostic capacity of pretreatment hematological parameters in patients with Head and neck cancer treated with chemo-bio Radiotherapy
Monetzuma, LC, Crespo, S, Leon, X, Majercakova, K, Rojas, J, Piedra, M, Calvet, G, Rabi, S, Julia, JC, Sancho, G. Prognostic capacity of pretreatment hematological parameters in patients with Head and neck cancer treated with chemo-bio Radiotherapy. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).
01/05/2025
CBCT dose optimisation in prostate IGRT
Perea, AD, Sala, NJ, Martínez, AR, Pagès, MB, García, JR, Marcos, CA, Molinero, VR, Fernandez, JPA, Franco, PG, Aguilar, NT, Bargalló, HV, Rey, EMA, Martin, AR, Arnal, CF, Gomez, MVM, Parreño, IA, Moreno, SG, González, JMR, Rull, FJC, Martin, DM, Deulofeu, AM, Martínez, SB, Errasti, AM, Pardo, GS, de Fez, PC. CBCT dose optimisation in prostate IGRT. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).